Overview
CUGENE Inc. is a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines that harness specific immune cells to treat autoimmune disease and cancer. We have an experienced leadership team with proven industrial R&D expertise and successful drug development records. Our innovation and discovery engine has been funded by dedicated investment groups.